MICRO THERAPEUTICS' LIQUID EMBOLIC SYSTEM TO ENTER CLINICALS EARLY IN 1997; FIRM EXPECTS $21.8 MIL. IN NET PROCEEDS FROM 2 MIL. SHARE INITIAL PUBLIC OFFERING
This article was originally published in The Gray Sheet
Executive Summary
Micro Therapeutics' Liquid Embolic System for treatment of arteriovenous malformations (AVMs) and aneurysms in the brain is anticipated to enter clinical trials in the first half of 1997, the firm says in a registration statement for an initial public offering.